 |
0 Diseases |  |
2 Trials |
|
2 Trials |  |
142 News |  |
| «123 |
- | cabiralizumab (BMS-986227) / Ono Pharma, BMS
New P1/2 trial: Dt-TGCT: Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor (clinicaltrials.gov) - Jun 15, 2015
P1/2, N=45, Not yet recruiting, Sponsor: Five Prime Therapeutics, Inc.
- || cabiralizumab (BMS-986227) / Ono Pharma, BMS
Trial primary completion date: Phase 1 Single and Multiple Dose Study of FPA008 in Healthy Volunteers and Rheumatoid Arthritis Subjects (clinicaltrials.gov) - Nov 13, 2014
P1, N=89, Recruiting, Sponsor: Five Prime Therapeutics, Inc.
Trial primary completion date: Nov 2015 --> Nov 2016
- ||| cabiralizumab (BMS-986227) / Ono Pharma, BMS
New P1 trial: Phase 1 Single and Multiple Dose Study of FPA008 in Healthy Volunteers and Rheumatoid Arthritis Subjects (clinicaltrials.gov) - Oct 10, 2013
P1, N=89, Recruiting, Sponsor: Five Prime Therapeutics, Inc.